Patient P-02127

Synthetic patientMETA-24 · Day 177 · 45–54 · F · baseline S11Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S11
Day 52 SC-12 recommended — Supportive Compound SC-12
Day 53 Patient accepted — Started SC-12 in the companion
Day 59 GI symptom burden −16% vs expected — Supportive Compound SC-12
Day 65 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity+7
Nutritional resilience-5
GI instability-4
Inflammatory activity-3

What helped?

Supportive Compound SC-12Day 52
Result: symptom burden −16%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

46 min

improving · +2.6 vs previous 14 d

Sleep duration

Wearable

6.8 h

improving · +0.3 vs previous 14 d

Energy level

Daily log

7.3/10

improving · +0.8 vs previous 14 d

Steps

Wearable

5,050

improving · +550 vs previous 14 d

GI burden

Companion

11.1/100

improving · -3.7 vs previous 14 d

Adherence

Companion

96 %

stable · +2.8 vs previous 14 d

Sleep quality

Wearable

53.8/100

improving · +6.4 vs previous 14 d

Glucose, CGM daily mean

CGM

131 mg/dL

stable · -4.4 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 91 from the failing basin, 11 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -3.7 next day on high-intake days · n 22

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.7supporter · 95%
Dietary fat load
+1.4no signal · 17%
Insoluble fibre
+1.3no signal · 41%
Caffeine
+1.2no signal · 38%
Alcohol
-1.2no signal · 35%
Simple carbohydrates
-1.1no signal · 33%
Ultra-processed food
-0.7no signal · 22%
Histamine load
+0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.9 · butyrate capacity 74/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 60 ms
Sleep: 6.5 h
Steps: 5,657
Resting HR: 56 bpm

Daily log: GI score 11, nutritional resilience 64, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	42%	S01	AD-05	no change	79
P-02277	37%	S05	AD-05	improved	92
P-02282	36%	S01	BR-03	no change	88
P-02013	35%	S14	BR-03	no change	94
P-02280	30%	S07	BR-03	no change	50
P-02193	33%	S11	CR-01	improved	87
P-02565	49%	S09	DT-01	no change	79
P-02337	35%	S18	DT-01	no change	100
P-02081	34%	S20	DT-01	no change	88
P-02462	33%	S12	DT-01	improved	65
P-02218	32%	S01	DT-01	improved	61
P-02249	32%	S09	DT-01	improved	100